Reckitt Benckiser LLC v. Aurobindo Pharma Ltd.
Reckitt Benckiser LLC v. Aurobindo Pharma Ltd.
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________
RECKITT BENCKISER LLC, Plaintiff-Appellant
v.
AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA INC., Defendants-Cross-Appellants ______________________
2017-1895, 2018-1131 ______________________
Appeals from the United States District Court for the District of Delaware in No. 1:14-cv-01203-LPS, Chief Judge Leonard P. Stark. ______________________
JUDGMENT ______________________
DOUGLAS J. NASH, Barclay Damon, LLP, Syracuse, NY, argued for plaintiff-appellant. Also represented by LAURA VOGEL, Boston, MA; BELLA SATRA, Albany, NY.
TIMOTHY KRATZ, Kratz & Barry LLP, Atlanta, GA, argued for defendants-cross-appellants. Also represented by GEORGE BARRY, III. _____________________ THIS CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
PER CURIAM (PROST, Chief Judge, MOORE and REYNA, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
September 10, 2018 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court
Reference
- Status
- Unpublished